Evidence map›Paper›PMID 22318245›Full record

ArticleTransplantation2012

A new enzyme mixture to increase the yield and transplant rate of autologous and allogeneic human islet products.

A N Balamurugan, Gopalakrishnan Loganathan, Melena D Bellin, Joshua J Wilhelm, James Harmon, Takayuki Anazawa, Sajjad M Soltani, David M Radosevich, Takeshi Yuasa, Mukesh Tiwari and 4 more

Abstract readComparative Study
In one paragraph

Article in Transplantation, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Sitagliptin Treatment After Total Pancreatectomy With Islet Autotransplantation: A Randomized, Placebo-Controlled Study.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2017
    Trial
  5. Trial
  6. Trial
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Metabolic measures before surgery and long-term diabetes outcomes in recipients of total pancreatectomy and islet autotransplantation.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2021
    Article
  13. Article
  14. Antioxidant Therapy in Pancreatitis.Antioxidants (Basel, Switzerland) · 2021
    Review
  15. Article
  16. Article
  17. Considerations for an Alternative Site of Islet Cell Transplantation.Journal of diabetes science and technology · 2020
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

A N BalamuruganSchulze Diabetes Institute, University of Minnesota, Minneapolis, MN 55455, USA. bala@umn.edu
Gopalakrishnan Loganathan
Melena D Bellin
Joshua J Wilhelm
James Harmon
Takayuki Anazawa
Sajjad M Soltani
David M Radosevich
Takeshi Yuasa
Mukesh Tiwari
Klearchos K Papas
Robert McCarthy
David E R Sutherland
Bernhard J Hering

Funding

Advancing Islet Transplants for Type 1 Diabetes CareU01AI065193 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI HERING, BERNHARD JOSEF · 2004 to 2008
$9.3M
HUMAN PANCREATIC ISLET CELL RESOURCES TYPE 1 DIABETESU42RR016598 · NCRR · UNIVERSITY OF MINNESOTA TWIN CITIES · PI HERING, BERNHARD JOSEF · 2001 to 2008
$6.8M
TOLERANCE TO ISLET ALLOGRAFTS IN TYPE I DIABETESR01DK056963 · NIDDK · UNIVERSITY OF MINNESOTA TWIN CITIES · PI HERING, BERNHARD JOSEF · 2000 to 2005
$4.5M
Sitagliptin therapy to improve outcomes after islet autotransplantation.K23DK084315 · NIDDK · UNIVERSITY OF MINNESOTA · PI BELLIN, MELENA D. · 2010 to 2014
$816k
NCRR NIH HHS U42 RR016598NCRR NIH HHS U42 RR16598NIAID NIH HHS AI-065193NIAID NIH HHS U01 AI065193NIDDK NIH HHS K23 DK084315NIDDK NIH HHS R01 DK056963NIDDK NIH HHS R01 DK56963
6 · The paper itself

Abstract

backgroundThe optimal enzyme blend that maximizes human islet yield for transplantation remains to be determined. In this study, we evaluated eight different enzyme combinations (ECs) in an attempt to improve islet yield. The ECs consisted of purified, intact or truncated class 1 (C1) and class 2 (C2) collagenases from Clostridium histolyticum (Ch), and neutral protease (NP) from Bacillus thermoproteolyticus rokko (thermolysin) or Ch (ChNP).

methodsWe report the results of 249 human islet isolations, including 99 deceased donors (research n=57, clinical n=42) and 150 chronic pancreatitis pancreases. We prepared a new enzyme mixture (NEM) composed of intact C1 and C2 collagenases and ChNP in place of thermolysin. The NEM was first tested in split pancreas (n=5) experiments and then used for islet autologous (n=21) and allogeneic transplantation (n=10). Islet isolation outcomes from eight different ECs were statistically compared using multivariate analysis.

resultsThe NEM consistently achieved higher islet yields from pancreatitis (P<0.003) and deceased donor pancreases (P<0.001) than other standard ECs. Using the NEM, islet products met release criteria for transplantation from 8 of 10 consecutive pancreases, averaging 6510 ± 2150 islet equivalent number/gram (IEQ/g) pancreas and 694,681 ± 147,356 total IEQ/transplantation. In autologous isolation, the NEM yielded more than 200,000 IEQ from 19 of 21 pancreases (averaging 422,893 ± 181,329 total IEQ and 5979 ± 1469 IEQ/kg recipient body weight) regardless of the severity of fibrosis.

conclusionsA NEM composed of ChNP with CIzyme high intact C1 collagenase recovers higher islet yield from deceased and pancreatitis pancreases while retaining islet quality and function.

Indexed as

Islets of Langerhans TransplantationAdultBacillaceaeChi-Square DistributionEndopeptidasesFemaleHathewaya histolyticaHumansIslets of LangerhansMaleMicrobial CollagenaseMiddle AgedMinnesotaMultivariate AnalysisRegression AnalysisThermolysinEndopeptidasesMicrobial CollagenaseThermolysin

Identifiers

PMID22318245
PMCPMC3314155

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.